Incoming GPhA leader has spent five years spearheading PhRMA's advocacy efforts at state, federal, international levels Davis The Generic Pharmaceutical Association has tapped the head of the advocacy team at the Pharmaceutical Research and Manufacturers of America as its next CEO. Chester "Chip" Davis is executive vice president for advocacy and member relations at PhRMA, where he leads the association's federal, state and international government relations and advocacy efforts and is responsible for membership recruitment and retention. He will begin his new job as CEO of GPhA on Aug. 18, replacing Ralph Neas. "(Davis') leadership skills, policy experience and deep… Read More